The 2026 Nobel Prize in Chemistry went to Henri B. Kagan and Kensō Soai, "for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis".
Underneath that phrasing is a problem with real consequences: many molecules exist in two mirror-image forms, biology responds to only one of them, and ordinary chemistry has no way to prefer one over the other.
Learning to make just the form you want is one of the most practically important problems in chemistry. These two prizes are for the discoveries that made it tractable.
Molecules With a Left and a Right
Hold your hands up. They contain the same parts, connected the same way, and they are mirror images — yet you cannot superimpose one on the other. A left glove does not fit a right hand.
Many molecules are like this. Same atoms, same connections, two arrangements in space that are mirror images and cannot be made to coincide. Chemists call the property chirality, from the Greek for hand, and the two forms enantiomers.
For a long time this looked like a geometric curiosity. It is not, because biology is itself handed. Your enzymes and receptors are chiral objects, so they interact with one enantiomer and not the other — exactly as a right hand meets a right glove and refuses a left one.
The consequence is that one enantiomer of a compound can be an effective drug while its mirror image is inert — or worse. The thalidomide disaster is why the point is taught in every chemistry course, and why regulators now take the handedness of a drug extremely seriously.
The Problem: Chemistry Has No Preference
Here is the difficulty. A reaction creating a chiral centre normally has no reason to favour one arrangement over the other. The two outcomes are energetically equivalent, so you get roughly 50:50 — a mixture chemists call racemic.
You can then separate the two, but separation is expensive, wasteful and often hard. Half of what you made is, at best, not the product you wanted.
So the goal became asymmetric synthesis: persuading the reaction itself to produce mostly one form. The usual approach is to introduce a chiral helper — a catalyst or auxiliary that is itself single-handed — so the reaction has a reason to prefer one path.
And this is where a sensible assumption turned out to be wrong.
Kagan: Impure Catalysts Can Outperform Themselves
Everyone assumed the relationship was proportional. A catalyst that is 50% single-handed gives a product that is 50% single-handed. Use a purer catalyst, get a purer product.
In 1986 Kagan showed that is not how it works. His own review, written with Christian Girard a decade later, puts it best:
"Who would have thought before 1986 that an enantiomerically impure catalyst could give a product in an asymmetric synthesis with an enantiomeric excess higher than that of the catalyst? Until then it was assumed that the ee value of the product … was linearly correlated to the ee value of the chiral auxiliary — in fact a large deviation is possible."
The Royal Swedish Academy describes the same discovery as a way "of manipulating chemical reactions, allowing a greater excess of one of the mirror images to be created than was previously assumed possible."
These are non-linear effects. A catalyst that is only partly single-handed can deliver a product that is substantially more single-handed than itself. Practically, that means an expensive, perfectly pure catalyst is sometimes unnecessary — and theoretically, it means a small imbalance can be converted into a larger one.
Hold on to that second point.
Soai: A Reaction That Makes More of Itself
Kagan showed that imbalance can be amplified. Soai found a reaction that amplifies its own.
In 1995 he reported a reaction in which the product acts as the catalyst for its own formation — asymmetric autocatalysis. Because the product is chiral, and because it catalyses the making of more of itself, any initial excess of one form feeds forward into a larger excess.
The numbers are what make it extraordinary. According to the Academy, Soai's 1995 work showed a 2% initial excess becoming 87%. By 2003, the refined reaction reached up to 99.99% enantiomeric purity.
Start with a sample that is very nearly a 50:50 mixture — tilted by two parts in a hundred — and run the reaction. It comes back overwhelmingly one-handed, with no other source of handedness involved.
The Academy's summary is that Soai "designed the first chemical reaction in which only one of the potential mirror images was formed."
Two Discoveries, One Idea
Both show that a small asymmetry need not stay small.
| Discovery | What was shown | Why it mattered |
|---|---|---|
| DiscoveryKagan, 1986 | What was shownAn impure chiral catalyst can give a product purer than itself | Why it matteredBroke the assumed proportional relationship |
| DiscoverySoai, 1995 | What was shownA product that catalyses its own formation amplifies its own excess | Why it mattered2% excess became 87% |
| DiscoverySoai, by 2003 | What was shownThe refined reaction reached up to 99.99% purity | Why it matteredEffectively a single-handed product |
Amplification, not creation
Neither discovery conjures handedness from nothing. Both take an imbalance that already exists and make it decisive.
Why This Looked Impossible
There is a reason chemists did not expect any of this, and it is worth following, because it explains exactly what was and was not achieved.
Start with achiral ingredients — molecules that are identical to their own mirror images — and run them under achiral conditions. Nothing in that system distinguishes left from right. Every pathway leading to the left-handed product has an exact mirror-image pathway leading to the right-handed one, with identical energies and identical rates.
If the two outcomes are equally favoured, you get equal amounts of each. That is not an engineering shortfall; it follows from the symmetry of the situation. A perfectly symmetric system cannot produce an asymmetric result.
So handedness has to come from somewhere. Conventionally it is supplied deliberately — a single-handed catalyst or auxiliary, which breaks the symmetry on purpose. That works, and it is why the chiral helper existed in the first place.
What Kagan and Soai changed is the exchange rate. Before 1986 the assumption was that you got out roughly what you put in: a half-handed catalyst bought you a half-handed product. Kagan showed that trade can run strongly in your favour. Soai showed that under autocatalysis it can run almost without limit — a 2% seed converted into 87%, and later into near-total purity.
Notice that neither result violates the symmetry argument, and this is the point the band above makes. Soai's reaction still needs the seed. It does not conjure handedness from a perfectly symmetric starting point; it takes a tiny existing imbalance and makes it overwhelming.
That distinction is what splits the origin-of-life question cleanly into two separate problems — where the first imbalance came from, and what amplified it. These prizes decisively address the second.
Why This Reaches Into the Origin of Life
There is a genuinely strange fact about biology: it is single-handed, universally.
The amino acids in your proteins are almost all one enantiomer. The sugars in your DNA are almost all the other. Every known organism uses the same handedness — a property called homochirality — and as far as chemistry is concerned, there is no reason it had to be this way. Mirror-image life would work equally well.
So how did a presumably symmetric prebiotic chemistry end up committed to one hand?
The leading class of explanation does not require a large original bias. It requires only a small one — from some chance fluctuation or physical asymmetry — plus a mechanism that can amplify it into dominance.
That second requirement is exactly what Kagan and Soai supplied. The Academy explicitly frames Kagan's discovery as fulfilling a condition of a theoretical model proposed decades earlier by Frank, which had predicted that autocatalysis plus amplification could tip a symmetric system into a single-handed one.
The Soai reaction is not a claim about what actually happened on the early Earth. It is a demonstration that the required chemistry is real — that a 2% imbalance genuinely can become 87%, in a flask, with nothing else providing handedness.
For more on how chemistry gets pressed into biological service, see our guide to synthetic biology.
What This Does Not Settle
Worth being careful about the limits, because this area attracts overstatement.
It does not explain where the first imbalance came from. Amplification needs something to amplify. Candidate sources — circularly polarised light in star-forming regions, parity violation in the weak force, chance — remain debated, and this work does not adjudicate between them.
The Soai reaction is unusual. It is a specific transformation with specific reagents, and chemists have spent three decades working out exactly how it achieves what it does. It is a proof of principle, not a general-purpose recipe.
And prebiotic plausibility is a separate question from laboratory demonstration. Showing that autocatalytic amplification can happen is not the same as showing it did.
None of that diminishes the chemistry. It is the difference between "this mechanism is available" and "this is what occurred", and the first claim is the one the evidence supports.
The Bottom Line
Molecules come in mirror-image forms. Biology can tell them apart; ordinary chemistry cannot, and produces a 50:50 mixture.
Kagan showed in 1986 that the relationship between a catalyst's purity and its product's purity is not proportional — an impure catalyst can deliver a product purer than itself. Soai showed in 1995 that a reaction can catalyse its own formation and amplify its own imbalance, turning 2% into 87%, and by 2003 into essentially a single-handed product.
Practically, that is how pharmaceutical chemistry makes the form of a drug that works rather than the one that does not. Theoretically, it is the best laboratory evidence that life's universal handedness could have started from a very small nudge.
For the other prizes see our guide to the 2026 Nobel Prizes, and the companion deep dives on optogenetics and IceCube. More in our biology hub.
Frequently Asked Questions
What is a chiral molecule?
One that exists in two mirror-image forms which cannot be superimposed on each other, like your left and right hands. The two forms are called enantiomers. They contain identical atoms connected in an identical order, differing only in their arrangement in three-dimensional space.
Why does molecular handedness matter in medicine?
Because the body is itself chiral. Enzymes and receptors are handed objects, so they bind one enantiomer and often ignore or mishandle the other. The same compound can therefore be effective in one form and inert — or harmful — in its mirror image, which is why regulators treat the handedness of a drug as a central question rather than a detail.
What is a non-linear effect in asymmetric synthesis?
The finding, reported by Kagan in 1986, that the purity of a product need not track the purity of the chiral catalyst in a straightforward proportional way. A catalyst that is only partly single-handed can yield a product that is substantially more single-handed than the catalyst itself — which was not expected.
What is asymmetric autocatalysis?
A reaction whose product acts as the catalyst for its own formation. Because the product is chiral, any initial excess of one mirror form is fed forward into making more of that same form. Soai's reaction demonstrated this in 1995, turning a 2% excess into 87% according to the Royal Swedish Academy, and reaching up to 99.99% purity by 2003.
Does this explain the origin of life's handedness?
Partly. All known life is single-handed, and these discoveries show that a very small initial imbalance can be amplified into near-total dominance by ordinary chemistry. What they do not explain is where the first imbalance came from — candidate sources are still debated — or whether this is what actually happened on the early Earth.
Why can't chemists just separate the two forms?
They can, but it is expensive and wasteful. Enantiomers have nearly identical physical properties, so separating them requires specialised methods, and you discard up to half of what you made. Making the desired form directly is cheaper, cleaner and often the only practical route at industrial scale.
Sources
- The Royal Swedish Academy of Sciences — They solved chemistry's asymmetric mystery (2026 Chemistry Prize)
- Girard & Kagan — Nonlinear Effects in Asymmetric Synthesis and Stereoselective Reactions, Angewandte Chemie (1998)
- Soai, Shibata, Morioka & Choji — Asymmetric autocatalysis and amplification of enantiomeric excess of a chiral molecule, Nature 378, 767–768 (1995)
- The Nobel Prize in Chemistry 2026
